US investment bank JP Morgan expects a full recovery of the global economy next year. The world is said to be able to end the coronavirus pandemic and markets will gradually return to equilibrium.
Pharmaceutical companies will have the main credit for this. According to JP Morgan analysts, they will be able to offer not only a new generation of vaccines against coronavirus variants, but also effective treatment of covid in the form of pills (some companies are already applying for their approval by regulators).
“Our outlook is that 2022 will be a year of full global recovery, end of pandemic and return to normal as we know it from before the coronavirus pandemic,” said Marko Kolanovic, JP Morgan’s chief strategist for global markets.
According to him, the world economy will experience a strong recovery, growth in demand for goods and services, which will be possible to satisfy, because global supply chains will also return to normal. Including sea and air transport. Stock markets will also rise next year, as will interest rates in response to persistently high inflation.
